Los más leídos

Lo más leído en Cirugía torácica

314
New Etiological Agents of Silicosis
Antonio León-Jiménez
Arch Bronconeumol. 2023;59:479-80
314
Acceso a texto completo
280
What is the Best Antihypertensive Treatment for OSA?
José Gilvam A. Lima-Junior, Ana Vitoria Vitoreti Martins, Luciano F. Drager
Arch Bronconeumol. 2023;59:548-9
280
Acceso a texto completo
277
Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis
L. Cobo Sanchez, C. Ruiz Herrero, I. Cobos, J. Bespin, C. Gadea, P. Cerdá-Cortés, J. Palma, V. Vicens-Zygmunt, ... Maria Molina-Molina
Arch Bronconeumol. 2023;59:526-30
277
Acceso a texto completo
233
When and When Not to Prescribe Home Oxygen in COPD
Yves Lacasse, François Maltais
Arch Bronconeumol. 2023;59:350-1
233
Acceso a texto completo
211
Obese Asthma Syndrome: Much Work to Do
Ebymar Arismendi, Marina Bantulà, César Picado
Arch Bronconeumol. 2023;59:473-5
211
Acceso a texto completo
211
Evolution of Tobacco Control in Latin America: What Has Been Achieved and What Is Pending
Susana Luhning, Daniel Buljubasich, Gabriela Senatore
Arch Bronconeumol. 2023;59:476-8
211
Acceso a texto completo
207
Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib
Michele Mondoni, Francesco Varone, Fausta Alfano, Giuseppe Muscato, Caterina Conti, Laura Saderi, Bruno Iovene, Fabiano Di Marco, ... Giovanni Sotgiu
Arch Bronconeumol. 2023;59:464-6
207
Acceso a texto completo
201
Urinothorax Secondary to Bilateral Rupture of the Ureters: An Unusual Case of Pleural Exudate
Almudena González-Montaos, Iván Rodríguez-Otero, Elena Chávarri-Ibáñez
Arch Bronconeumol. 2023;59:389-90
201
Acceso a texto completo
185
Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations
Juan Marco Figueira-Gonçalves, Rafael Golpe
Arch Bronconeumol. 2023;59:412-3
185
Acceso a texto completo
178
Functional Brain Imaging in the Treatment of Nicotine Dependence
Violeta Esteban Ronda, Esther Pastor Esplá, Carlos Rábade Castedo
Arch Bronconeumol. 2023;59:543-5
178
Acceso a texto completo
177
Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease
Juan Marco Figueira-Gonçalves, José María Hernández-Pérez, Carlos Cabrera-Lopez, Aurelio Luis Wangüemert-Pérez, Ignacio García-Talavera, Yolanda Ramallo-Fariña, Rafael Golpe, Luis Manuel González-García
Arch Bronconeumol. 2023;59:403-5
177
Acceso a texto completo
163
Nocardia and Tuberculosis Pulmonary Coinfection Mimicking Pancoast Tumor in an Immunocompetent Host
Juan Blas Pérez-Gilaberte, Elisa García-Arceiz, Manuel David Viñuales-Aranda
Arch Bronconeumol. 2023;59:385-6
163
Acceso a texto completo
158
Deposition and Clinical Impact of Inhaled Particles in the Lung
Pere Casan Clarà, Francisco Rodríguez Jerez, José Belda Ramírez, Cristina Martínez González
Arch Bronconeumol. 2023;59:377-82
158
Acceso a texto completo
152
Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?
Nan Zhao, Samy Suissa, Pierre Ernst
Arch Bronconeumol. 2023;59:354-5
152
Acceso a texto completo
151
A Red Herring to Iatrogenic Pneumothorax
Natalia Beatriz Mena Casado, Manuel Cuesta Martín
Arch Bronconeumol. 2023;59:387-8
151
Acceso a texto completo
150
Bullous Lung Disease Post-COVID
Carlos Manzano Senra, Ricard Pifarré Teixidó, Marina Asunción Pardina Solano
Arch Bronconeumol. 2023;59:393
150
Acceso a texto completo
145
Researchers Forget to Report How to Share Data From Studies Published in Spanish Medical Journals
Rafael Dal-Ré
Arch Bronconeumol. 2023;59:461-3
145
Acceso a texto completo
145
The MAPK Pathway in Pulmonary Langerhans Cell Histiocytosis
Fanélie Jouenne, Abdellatif Tazi
Arch Bronconeumol. 2023;59:347-9
145
Acceso a texto completo
144
Alpha-1 Antitrypsin Deficiency and SERPINA1 Variants Could Play a Role in Asthma Exacerbations
José M. Hernández-Pérez, Elena Martín-González, Mario A. González-Carracedo
Arch Bronconeumol. 2023;59:416-7
144
Acceso a texto completo
140
New Questions, Warmings and Answers Related to High Flow Therapy in 2022
Sarah Heili-Frades, Alba Naya Prieto, Pilar Carballosa de Miguel
Arch Bronconeumol. 2023;59:409-11
140
Acceso a texto completo